HOME >> MEDICINE >> NEWS
The Lancet Oncology and The Lancet Infectious Diseases

THE LANCET ONCOLOGY

THE TRUE COST OF A NUCLEAR DETERRENT

This months editorial covers the recent leaked report from the US Department of Health and Disease Control, showing the patterns of nuclear fallout across the US resulting from Cold War testing. The editorial discusses the impact of these data on cancer incidence and the worldwide effects of nuclear testing on the general population and military personnel. It concludes: 'It is easy to say that lessons should be learnt from the history of the nuclear deterrent, but unfortunately, with the escalation of the nuclear race in India and Pakistan, and the possibility of terrorist groups such as al-Qaeda acquiring materials to create crude nuclear devices, it is likely that the same mistakes will be repeated. We may never fully realise the true human cost of military advancement.'

REVIEWS

  • The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators
  • Use of minimally invasive oesophagectomy for cancer of the oesophagus
  • Clinical management of dyspnoea
  • Mediastinal (thymic) large B-cell lymphoma: where do we stand?
  • Culprit and victim - DNA topoisomerase II
  • Cancer causation: the Darwinian downside of past success?

THE LANCET INFECTIOUS DISEASES

ENOUGH TIME WASTED IN SOUTH AFRICA

This months Leading Edge editorial discusses the South African Governments reluctance to provide the antiretroviral drug nevirapine to pregnant women with HIV. The drug has been shown to be effective in preventing mother-to-child HIV-1 transmission; however the South African Government have recently launched an appeal to a March 11 court hearing which instructed them to make the drug available in state facilities offering HIV-1 counselling and testing.

REVIEWS

  • Epidemiology of drug-resistant malaria
  • p values for pathogens: statistica
    '"/>


Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
1-Apr-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. The Lancet Neurology November press release
7. Lancet readers to join WHO election debate
8. The Lancet Oncology press release
9. The Lancet Neurology October press release
10. The Lancet neurology press release
11. The Lancet Neurology press release

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Lancet Oncology and The Lancet Infectious Diseases

(Date:5/30/2015)... Cyclist Barry Haarde will commence his ... 2015: Piles of Miles” near San Francisco, California ... and encourage individuals to support needy hemophilic children ... Life supports nearly 1,200 impoverished children and adults ... sponsorships, scholarships and micro-enterprise grants. Hemophilia is a ...
(Date:5/30/2015)... iconic American actor, and host of “In America” James ... Medical Malpractice. This segment of “In America” will cover ... field. , According to the Bureau of Justice Statistics, ... roughly only 20% of them made it to court, ... remaining 30% were tossed out. (Source: http://www.bjs.gov/index.cfm?ty=tp&tid=4511 ) ...
(Date:5/30/2015)... May 30, 2015 Venus Viva has ... scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, ... professional, such as Dr. F. Victor Rueckl of Lakes ... clinical trials in Las Vegas. This body image solution ... a system that delivers proven results through a skin ...
(Date:5/29/2015)... Based in St. Louis, Missouri La La ... for a couple of months now and are really helping ... reads “I’m not misbehaving, I have Autism, please be understanding” ... an autistic child in order to start a conversation and ... are they raising awareness through the autism awareness shirts which ...
(Date:5/29/2015)... Washington, PA (PRWEB) May 29, 2015 ... ” quiz-based learning in 14 medical specialties, now offers ... includes a wide spectrum of rheumatology disorders ranging from ... Alfred Saint Jacques, editorial director of MDLinx, and Caroline ... excited about the impact it will have on the ...
Breaking Medicine News(10 mins):Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:MDLinx Launches Smartest Rheumatologist 2
(Date:5/29/2015)... , May 29, 2015  Anpac Bio-Medical Science Co., ... Yu and the Anpac research team are introducing ... Science (NPLS) organizers published as, "game changing" and "breakthrough" ... Society of Clinical Oncology (ASCO) Annual Meeting in ... 2, 2015. An accomplished inventor with ...
(Date:5/29/2015)... , May 29, 2015  Fair Rate Funding, ... a state-court jury in Delaware ... inserts, designed to treat pelvic organ prolapse (POP) and ... and that company executives hid the design flaws from ... - http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal mesh, ...
(Date:5/29/2015)... Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., ... Foundation Venture Capital Group (FVCG), have been selected to ... of the Start-Up Stadium and Company Presentation forums offered ... Golubieski . The annual convention, the largest ... in Philadelphia in June. ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3
Cached News: